FDA Adverse Event Malfunction Summary report: N

ELECSYS AFP ASSAY

MDR report key: 6940687 · Received October 11, 2017

Report

Report Number
1823260-2017-02269
Event Type
Malfunction
Date Received
October 11, 2017
Date of Event
September 25, 2017
Report Date
October 24, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LOJ
PMA / PMN Number
K981282
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. THE INVESTIGATION STATED THE MEASURED AFP VALUE OF A PATIENT'S SAMPLE CAN VARY DEPENDING ON THE TESTING PROCEDURE USED. AFP VALUES DETERMINED ON PATIENT SAMPLES BY DIFFERENT TESTING PROCEDURES CANNOT BE DIRECTLY COMPARED WITH ONE ANOTHER AND COULD BE THE CAUSE OF ERRONEOUS MEDICAL INTERPRETATIONS. THIS INFORMATION IS DOCUMENTED IN PRODUCT LABELING FOR THE ASSAY.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). (B)(4).

Description of Event or Problem · 1

THE CUSTOMER COMPLAINED OF ERRONEOUS RESULTS FOR 1 PATIENT SAMPLE TESTED FOR ELECSYS AFP ASSAY (AFP) ON A COBAS 8000 E 602 MODULE. THE INITIAL AFP RESULT FROM THE E602 MODULE WAS 15.0 NG/ML. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS SENT TO AN EXTERNAL LABORATORY AND REPEATED USING THE LIGAND BINDING ASSAY METHOD FROM WAKO AND THE RESULT WAS 5.7 NG/ML. THE CUSTOMER DOES NOT KNOWN WHICH RESULT IS CORRECT. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE E602 MODULE SERIAL NUMBER WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
722323 ELECSYS AFP ASSAY KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER LOJ ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1